Position in ARVN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$920,507
+$14,292 QoQ
Shares Held
110,771
+29.6% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 201 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,568,637,643 across 178 Biotechnology names. ARVN ranks #91 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in ARVN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $920,507 | 110,771 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $906,215 | 85,492 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $634,498 | 53,499 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $263,498 | 30,927 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $169,015 | 22,964 | Shares | Defined | 2025-08-12 | |
| 2024-12-31 | $4,843,971 | 252,685 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $7,671,579 | 311,473 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,667,205 | 325,590 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $13,437,383 | 325,518 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $16,273,305 | 395,367 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $15,976,531 | 813,469 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $21,344,703 | 859,980 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $22,836,241 | 835,880 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $31,658,549 | 925,418 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $34,562,412 | 776,858 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,003,451 | 736,599 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $41,564,883 | 617,606 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $41,364,554 | 503,586 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $32,147,008 | 391,178 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $30,106,384 | 390,992 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $24,862,721 | 376,138 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $38,461,824 | 452,865 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,959,870 | 210,075 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,052,264 | 150,634 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,879,882 | 96,275 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||